美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

53.50

-0.7500-1.38%

盘后：52.89-0.6100-1.14%19:54 EDT

成交量：54.81万

成交额：2,946.05万

市值：37.90亿

市盈率：-22.43

高：55.54

开：54.63

低：53.08

收：54.25

52周最高：94.90

52周最低：15.80

股本：7,084.18万

流通股本：5,139.47万

量比：0.62

换手率：1.07%

股息：- -

股息率：- -

每股收益(TTM):-2.3852

每股收益(LYR):-2.3276

净资产收益率：-11.86%

总资产收益率：-9.39%

市净率：2.50

市盈率(LYR):-22.99

数据加载中...

总览公司新闻资讯公告

Structure Therapeutics任命Matthew Lang为首席运营官兼总法律顾问

BUZZ-H.C. Wainwright表示，礼来肥胖药获批为Structure公司的药物创造了机会

美股异动 | 礼来(LLY.US)跌超4% 硕迪生物(GPCR.US)实验性减肥药公布积极数据

Structure肥胖药物研究结果直追诺和诺德与礼来

Structure Therapeutics股价上涨6% 公布实验性肥胖症药物中期试验结果

Structure Therapeutics股价逆转走势披露中期试验结果后盘前大涨13.5%

Structure Therapeutics盘前跌1.6% 披露实验性减肥药中期试验结果

研究显示，结构公司的肥胖药片最多可减轻 16.3% 的体重

Structure Therapeutics公司：FDA二期结束会议定于2026年第二季度；三期试验启动计划于2026年下半年推进

Structure Therapeutics中期数据：2.5毫克起始剂量组不良事件相关停药率为2.0%-3.4%

Structure Therapeutics公布每日一次口服小分子GLP-1受体激动剂Aleniglipron二期临床试验积极顶线数据

Structure Therapeutics公司ACCESS OLE研究显示：120毫克剂量在56周内实现持续减重，最高达16.2%

用于成人体重管理的新药获批，研究称患者治疗期内体重持续下降

Structure Therapeutics公布2025年末现金及等价物达14亿美元预计资金可支撑运营至2028年底

硕迪生物盘中异动大幅下挫5.12%报72.09美元

美国研究综述-Cencora、Crocs、Teledyne Technologies

硕迪生物(GPCR.US)CEO忧心减肥药仿制冲击：即便药物尚未上市，挑战已在眼前

Structure Therapeutics首席执行官强调：药品商业化战略伙伴需与基层医疗医生建立稳固关系

Structure 预计到 2030 年，药片将占据 25% 至 50% 的 GLP-1 肥胖症市场份额

未来一天的看点--1 月 14 日星期三

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GPCR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":53.5,"timestamp":1776369600000,"preClose":54.25,"halted":0,"volume":548121,"hourTrading":{"tag":"盘后","latestPrice":52.89,"preClose":53.5,"latestTime":"19:54 EDT","volume":19833,"amount":1061133.4731,"timestamp":1776383660025,"change":-0.61,"changeRate":-0.011402,"amplitude":0.014738},"delay":0,"changeRate":-0.013824884792626729,"floatShares":51394700,"shares":70841812,"eps":-2.385222,"marketStatus":"已收盘","change":-0.75,"latestTime":"04-16 16:00:00 EDT","open":54.63,"high":55.54,"low":53.08,"amount":29460500.68857,"amplitude":0.045346,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.385222,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":5,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":54.25,"preHourTrading":{"tag":"盘前","latestPrice":54.88,"preClose":54.25,"latestTime":"09:21 EDT","volume":2456,"amount":134265.917048,"timestamp":1776345664927,"change":0.63,"changeRate":0.011613,"amplitude":0.032995},"postHourTrading":{"tag":"盘后","latestPrice":52.89,"preClose":53.5,"latestTime":"19:54 EDT","volume":19833,"amount":1061133.4731,"timestamp":1776383660025,"change":-0.61,"changeRate":-0.011402,"amplitude":0.014738},"volumeRatio":0.617086,"impliedVol":0.8133,"impliedVolPercentile":0.692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":51394700,"roa":"-9.39%","roe":"-11.86%","lyrEps":-2.327592,"volumeRatio":0.617086,"shares":70841812,"dividePrice":0,"high":55.54,"amplitude":0.045346,"preClose":54.25,"low":53.08,"week52Low":15.8,"pbRate":"2.50","week52High":94.9,"institutionHeld":0,"latestPrice":53.5,"eps":-2.385222,"divideRate":0,"volume":548121,"delay":0,"ttmEps":-2.385222,"open":54.63,"prevYearClose":69.55,"prevWeekClose":54.51,"prevMonthClose":48.2,"prevQuarterClose":48.2,"fiveDayClose":55.14,"twentyDayClose":51.89,"sixtyDayClose":91.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"GPCR","fiscalQuarterEnding":"2025/12","expectedEps":-0.35,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-06","symbol":"GPCR","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-06","symbol":"GPCR","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-05-08","symbol":"GPCR","fiscalQuarterEnding":"2025/03","expectedEps":-0.24,"name":null,"time":"盘后","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-02-27","symbol":"GPCR","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"盘后","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.5882,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5882,"analysts":17,"updateTime":1774584000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2026-04-15","current":-22.429778,"percent":0.154242,"low":-50.180001,"twenty":-24.997625,"median":-19.66456,"eighty":-10.076195,"high":-5.211405,"avg":-19.373204,"sd":8.655426,"marketCap":3770201234},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-25","current":-11.068331,"twenty":-25.25285,"median":-20.951128,"eighty":-16.426861,"marketCap":1356158331},{"date":"2025-05-02","current":-12.790591,"twenty":-25.171712,"median":-20.933479,"eighty":-16.305436,"marketCap":1567180008},{"date":"2025-05-09","current":-12.551909,"twenty":-25.070517,"median":-20.891345,"eighty":-16.181125,"marketCap":1537935156},{"date":"2025-05-16","current":-9.774326,"twenty":-25.068859,"median":-20.829252,"eighty":-16.056814,"marketCap":1400885752},{"date":"2025-05-23","current":-9.895696,"twenty":-25.0453,"median":-20.693431,"eighty":-15.839386,"marketCap":1418280862},{"date":"2025-05-30","current":-9.000467,"twenty":-25.01052,"median":-20.672234,"eighty":-15.745511,"marketCap":1289973912},{"date":"2025-06-06","current":-8.619091,"twenty":-25.001825,"median":-20.550917,"eighty":-15.544032,"marketCap":1235314001},{"date":"2025-06-13","current":-8.920177,"twenty":-24.996225,"median":-20.487391,"eighty":-15.387426,"marketCap":1278466562},{"date":"2025-06-20","current":-8.679308,"twenty":-24.952868,"median":-20.449033,"eighty":-14.973238,"marketCap":1243944513},{"date":"2025-06-27","current":-8.462526,"twenty":-24.918331,"median":-20.434088,"eighty":-14.66039,"marketCap":1212874668},{"date":"2025-07-03","current":-8.175491,"twenty":-24.875783,"median":-20.408464,"eighty":-14.607558,"marketCap":1171735893},{"date":"2025-07-11","current":-7.587369,"twenty":-24.818526,"median":-20.385744,"eighty":-14.451133,"marketCap":1087444556},{"date":"2025-07-18","current":-7.840282,"twenty":-24.807686,"median":-20.281918,"eighty":-14.123781,"marketCap":1123692707},{"date":"2025-07-25","current":-7.334457,"twenty":-24.781668,"median":-20.180483,"eighty":-13.987039,"marketCap":1051196404},{"date":"2025-08-01","current":-7.145777,"twenty":-24.722332,"median":-20.085721,"eighty":-13.108576,"marketCap":1024154132},{"date":"2025-08-08","current":-5.211405,"twenty":-24.651853,"median":-19.971704,"eighty":-12.812535,"marketCap":932580977},{"date":"2025-08-15","current":-5.964179,"twenty":-24.61951,"median":-19.937893,"eighty":-12.626872,"marketCap":1067289809},{"date":"2025-08-22","current":-6.234546,"twenty":-24.540145,"median":-19.829477,"eighty":-12.490132,"marketCap":1115672078},{"date":"2025-08-29","current":-6.160517,"twenty":-24.4698,"median":-19.66456,"eighty":-12.119485,"marketCap":1102424552},{"date":"2025-09-05","current":-6.360074,"twenty":-24.389808,"median":-19.576169,"eighty":-11.77845,"marketCap":1138135274},{"date":"2025-09-12","current":-6.720564,"twenty":-24.139365,"median":-19.456275,"eighty":-11.057099,"marketCap":1202644966},{"date":"2025-09-19","current":-7.47695,"twenty":-24.11098,"median":-19.134734,"eighty":-10.896967,"marketCap":1338000122},{"date":"2025-09-26","current":-8.043434,"twenty":-24.072254,"median":-19.014985,"eighty":-10.567565,"marketCap":1439372495},{"date":"2025-10-03","current":-8.568076,"twenty":-24.020356,"median":-18.941828,"eighty":-10.325716,"marketCap":1533257136},{"date":"2025-10-10","current":-9.833009,"twenty":-23.986828,"median":-18.81071,"eighty":-10.186609,"marketCap":1759617036},{"date":"2025-10-17","current":-8.87063,"twenty":-23.947347,"median":-18.74276,"eighty":-9.917033,"marketCap":1587399198},{"date":"2025-10-24","current":-8.548764,"twenty":-23.914099,"median":-18.661907,"eighty":-9.852324,"marketCap":1529801259},{"date":"2025-10-31","current":-10.370526,"twenty":-23.886602,"median":-18.351918,"eighty":-9.836476,"marketCap":1855805594},{"date":"2025-11-07","current":-10.772858,"twenty":-23.868757,"median":-18.327399,"eighty":-9.850579,"marketCap":1927803018},{"date":"2025-11-14","current":-10.08006,"twenty":-23.852048,"median":-18.288418,"eighty":-9.817863,"marketCap":2123717400},{"date":"2025-11-21","current":-9.889979,"twenty":-23.841601,"median":-18.256152,"eighty":-9.836476,"marketCap":2083670157},{"date":"2025-11-28","current":-10.313341,"twenty":-23.799814,"median":-18.097181,"eighty":-9.841018,"marketCap":2172866288},{"date":"2025-12-05","current":-9.460856,"twenty":-23.776121,"median":-18.070517,"eighty":-9.814076,"marketCap":1993260474},{"date":"2025-12-12","current":-19.422835,"twenty":-23.650834,"median":-18.082412,"eighty":-9.833009,"marketCap":4092100041},{"date":"2025-12-19","current":-17.985707,"twenty":-23.62393,"median":-18.070517,"eighty":-9.841018,"marketCap":3789318618},{"date":"2025-12-26","current":-22.869735,"twenty":-23.621272,"median":-18.100056,"eighty":-9.848479,"marketCap":4818310220},{"date":"2026-01-02","current":-22.823793,"twenty":-23.615623,"median":-18.255492,"eighty":-9.851048,"marketCap":4808630734},{"date":"2026-01-09","current":-21.980412,"twenty":-23.576442,"median":-18.281194,"eighty":-9.851517,"marketCap":4630943013},{"date":"2026-01-16","current":-27.900487,"twenty":-23.621936,"median":-18.326514,"eighty":-9.853937,"marketCap":5878214018},{"date":"2026-01-23","current":-30.148409,"twenty":-23.790337,"median":-18.349084,"eighty":-9.86147,"marketCap":6351817477},{"date":"2026-01-30","current":-28.599475,"twenty":-23.883185,"median":-18.63625,"eighty":-9.874048,"marketCap":6025480495},{"date":"2026-02-06","current":-24.024872,"twenty":-24.012922,"median":-18.680713,"eighty":-9.881446,"marketCap":5061680173},{"date":"2026-02-13","current":-23.64092,"twenty":-24.104146,"median":-18.735704,"eighty":-9.886523,"marketCap":4980787319},{"date":"2026-02-20","current":-22.141212,"twenty":-24.072254,"median":-18.787312,"eighty":-9.891122,"marketCap":4664821216},{"date":"2026-02-27","current":-21.248606,"twenty":-24.026331,"median":-18.905431,"eighty":-9.903769,"marketCap":4476762617},{"date":"2026-03-06","current":-29.951815,"twenty":-24.389808,"median":-18.958825,"eighty":-9.939515,"marketCap":4229256176},{"date":"2026-03-13","current":-27.383083,"twenty":-24.63457,"median":-19.091174,"eighty":-9.953915,"marketCap":3866546098},{"date":"2026-03-20","current":-25.316057,"twenty":-24.813106,"median":-19.247915,"eighty":-9.965451,"marketCap":3574677833},{"date":"2026-03-27","current":-23.178791,"twenty":-24.786548,"median":-19.412443,"eighty":-10.00684,"marketCap":3272891714},{"date":"2026-04-02","current":-25.170562,"twenty":-24.791427,"median":-19.500107,"eighty":-10.024679,"marketCap":3554133708},{"date":"2026-04-10","current":-27.664038,"twenty":-24.924896,"median":-19.588971,"eighty":-10.070397,"marketCap":3906217513},{"date":"2026-04-15","current":-26.700764,"twenty":-24.997625,"median":-19.66456,"eighty":-10.076195,"marketCap":3770201234}],"updateTime":1776390036845},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1115849765","title":"Structure Therapeutics任命Matthew Lang为首席运营官兼总法律顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=1115849765","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115849765?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 04:07","pubTimestamp":1776197275,"startTime":"0","endTime":"0","summary":"旧金山，2026年4月14日——临床阶段全球生物制药公司Structure Therapeutics Inc.今日宣布，任命Matthew Lang, J.D. 为公司首席运营官兼总法律顾问。Lang先生在加入Structure Therapeutics时，已在全球生物制药机构拥有超过十五年的高管领导经验，其深厚专长涵盖法律、企业战略、合规、风险管理和业务发展等多个领域。Structure Therapeutics首席执行官Raymond Stevens博士表示：\"Matt是一位经验丰富的领导者，在引导组织实现增长和转型方面拥有卓越的业绩记录。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","LENZ","BK4539","BK4007","R","BK4232","BK4599","GPCR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624683807","title":"BUZZ-H.C. Wainwright表示，礼来肥胖药获批为Structure公司的药物创造了机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2624683807","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624683807?lang=zh_cn&edition=fundamental","pubTime":"2026-04-02 23:57","pubTimestamp":1775145467,"startTime":"0","endTime":"0","summary":"4月2日 - ** H.C. Wainwright称礼来公司的Foundayo  获得FDA批准是药物开发商Structure Therapeutics公司GPCR.O口服肥胖症项目的积极进展** 经纪公司维持GPCR股票的 \"买入 \"评级，目标价100美元。** H.C. Wainwright 说：\"我们认为 aleniglipron 是一种比 Foundayo 更具吸引力的降阶维持选择，因为从 Zepbound 或 Wegovy 转药的患者服用 16% 以上药物的反弹可能会大大低于服用 12% 药物的反弹\"。** 称礼来公司的药片定价较低，可以吸引更多患者，从而扩大口服肥胖症市场，如果 GPCR 的药片上市，这也会对其有所帮助。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL4S40L1IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620476982","title":"美股异动 | 礼来(LLY.US)跌超4% 硕迪生物(GPCR.US)实验性减肥药公布积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2620476982","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620476982?lang=zh_cn&edition=fundamental","pubTime":"2026-03-17 23:14","pubTimestamp":1773760452,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，礼来(LLY.US)股价低开低走，截至发稿，该股跌超4%，报948.76美元。消息面上，硕迪生物(GPCR.US)此前公布其实验性减肥药aleniglipron积极结果。数据显示，患者在服用44周后，体重减轻了约15%。BMO资本市场分析师Evan Seigerman指出，该药物的疗效“看起来极具竞争力”，甚至可能优于诺和诺德(NVO.US)和礼来的同类口服药。硕迪生物计划在2026年下半年启动后期研究，采用“低量且缓慢”的剂量滴定法以预防胃肠道副作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0256863902.USD","LU0203201768.USD","LU0203202063.USD","LU2357305700.SGD","LU2028103732.USD","LU0158827781.USD","LU2168564495.EUR","LU2237443978.SGD","LU2756315664.SGD","SGXZ81514606.USD","LU1720051017.SGD","LU1291159041.SGD","LU0289739699.SGD","LU0061475181.USD","LU1868837300.USD","LU2237443549.SGD","BK4581","LU2089284900.SGD","LU0006306889.USD","ELIS","IE0005OL40V9.USD","LU2471134796.USD","LU0689472784.USD","BK4007","LU0471298694.HKD","IE00BJT1NW94.SGD","LU2750360641.GBP","LU2111349929.HKD","LU0256863811.USD","IE00BKDWB100.SGD","LU0097036916.USD","LU0471298777.SGD","LU2602419157.SGD","SG9999014914.USD","LU1551013342.USD","SGXZ99366536.SGD","LU2456880835.USD","SG9999001176.USD","IE00B1BXHZ80.USD","LU0109391861.USD","LU1064131342.USD","LU0432979614.USD","LU0708995401.HKD","LU0820562030.AUD","LU2361045086.USD","LU2360106947.USD","SG9999013999.USD","LU0354030438.USD","LU0466842654.USD","LU1069344957.HKD","LU0079474960.USD","IE00BKPKM429.USD","LU2462157665.USD","LU2468319806.SGD","LU1366192091.USD","BK4533","LU0672654240.SGD","LU2746668974.SGD","IE00B4JS1V06.HKD","LU2265009873.SGD","LU1814569148.SGD","LU2089984988.USD","LU0109394709.USD","BK4585","LU2108987350.USD","LU0096364046.USD","BK4599","LU0964807845.USD","LU1712237335.SGD","LLY","LU0058720904.USD","IE00BN29S564.USD","LU2237443382.USD","SG9999001176.SGD","IE00BK4W5L77.USD","LLYX","LU1232071149.USD","LU0122379950.USD","LU0882574139.USD","LU0316494557.USD","SG9999015952.SGD","LU2023250330.USD","LU2236285917.USD","LU1868836591.USD","BK4534","LU1023059063.AUD","IE00BJLML261.HKD","LU2491050071.SGD","LU2552382058.USD","LU0210536198.USD","LU2361044865.SGD","LU0323591593.USD","LU2112291526.USD","LU2746668461.USD","LU2324357040.USD","IE00B775H168.HKD","LU2237443622.USD","LU0353189680.USD","LU2750360997.AUD","LU0786609619.USD","LU0456855351.SGD","GB00BDT5M118.USD","LU2106854487.HKD","LU0889565916.HKD","IE00B2B36J28.USD","IE0001KFT4U8.USD","LU0820561909.HKD","LU2237438978.USD","LU1868836914.USD","LU0198837287.USD","LU1988902786.USD","LU1917777945.USD","LU2491049909.HKD","LU2168563687.JPY","LU0820561818.USD","IE0002141913.USD","LU0683600562.USD","LU1093756168.USD","LU2417539215.USD","LU0266013472.USD","LU0823434583.USD","LU1623119135.USD","IE00BJJMRY28.SGD","LU1720051108.HKD","LU2237443895.HKD","LU2213496289.HKD","LU0640476718.USD","SG9999015986.USD","LU2168564065.EUR","LU0353189763.USD","IE0004445015.USD","LU0114720955.EUR","IE00BJJMRX11.SGD","IE0004445239.USD","LU2063271972.USD","SGXZ31699556.SGD","LU1551013425.SGD","SGXZ57979304.SGD","LU0787776722.HKD","LU1061106388.HKD","LU2087625088.SGD","LU2264538146.SGD","LU2168564149.EUR","LU1868836757.USD","LLII","LU1127390331.HKD","IE00BFSS8Q28.SGD","SG9999014880.SGD","LU0823434740.USD","SG9999015978.USD","LU2471134952.CNY","LU2211815571.USD","LU1989771016.USD","LU0158827948.USD","LU0882574055.USD","LU1280957306.USD","LU1868837136.USD","SG9999018857.SGD","LU2023251221.USD","LU2491050154.USD","LU0234572021.USD","GPCR","BK4588","LU1267930730.SGD","LU0417517546.SGD","IE00B7KXQ091.USD","LU1548497426.USD","LU0943347566.SGD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1057294990.SGD","LU1983299246.USD","LLYZ","SG9999015945.SGD","LU1974910355.USD","LU1093756325.SGD","SG9999017495.SGD","ELIL","LU0823416689.USD","IE00BWXC8680.SGD","LU2271345857.HKD","SG9999014906.USD","LU0320765059.SGD","LU1804176565.USD","BK4516","SG9999014898.SGD","LU0385154629.USD","IE00B1XK9C88.USD","LU0094547139.USD","LU0320765992.SGD","LU2237443465.HKD","LU1035775433.USD","LU2461242641.AUD","IE00BFTCPJ56.SGD","LU2756315318.SGD","LU0238689110.USD","LU2896262040.SGD","LU0106261372.USD","IE0009355771.USD","LU2023250504.SGD","IE00BFSS7M15.SGD","LU2089283258.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2168564222.USD","SGXZ51526630.SGD","LU0225283273.USD","LU0354030511.USD","LU2361044949.HKD","LU2471134879.HKD","SG9999018865.SGD","LU2552382132.HKD","LU2552382215.SGD","LU1629891620.HKD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620476890","title":"Structure肥胖药物研究结果直追诺和诺德与礼来","url":"https://stock-news.laohu8.com/highlight/detail?id=2620476890","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620476890?lang=zh_cn&edition=fundamental","pubTime":"2026-03-17 23:08","pubTimestamp":1773760090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2361045086.USD","LU2089984988.USD","LU1868837300.USD","LU2896262040.SGD","LU0823416689.USD","LU2264538146.SGD","LU2211815571.USD","LU1069344957.HKD","LU1366192091.USD","BK4516","LU0708995401.HKD","LU0256863811.USD","LU1291159041.SGD","LU1989771016.USD","LU0256863902.USD","LU1548497426.USD","LU0943347566.SGD","SG9999001176.USD","BK4532","LU0079474960.USD","LU1551013342.USD","LU1267930730.SGD","LU1323610961.USD","LU2236285917.USD","LU0353189763.USD","IE00BN29S564.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU0689472784.USD","SG9999015986.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRX11.SGD","LU2471134796.USD","GB00BDT5M118.USD","SG9999018865.SGD","LU0154236417.USD","LU0882574139.USD","SG9999015952.SGD","LU2602419157.SGD","BK4585","LU1868836757.USD","LU2237443549.SGD","IE00BFSS8Q28.SGD","IE0001KFT4U8.USD","LU2237443382.USD","LU1127390331.HKD","LU2471134952.CNY","LU2023250504.SGD","LU0061475181.USD","IE00BJLML261.HKD","LU0094547139.USD","LU2461242641.AUD","LU1917777945.USD","LU0006306889.USD","LU0058720904.USD","LU2237443978.SGD","LU0432979614.USD","IE00B1BXHZ80.USD","LU1093756168.USD","ELIS","LU0203202063.USD","LU0456855351.SGD","LU0158827948.USD","LU2357305700.SGD","LU1988902786.USD","LU0109391861.USD","SG9999014880.SGD","LU2552382215.SGD","LU0234572021.USD","LU2168563687.JPY","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0096364046.USD","LU1712237335.SGD","LU2417539215.USD","IE00B1XK9C88.USD","LU2756315664.SGD","LU2491049909.HKD","IE00BWXC8680.SGD","LU0198837287.USD","LLYX","LU0385154629.USD","LU2361044865.SGD","LU2471134879.HKD","BK4599","IE00B4JS1V06.HKD","IE00BJJMRZ35.SGD","LU1804176565.USD","LU2168564149.EUR","LU0882574055.USD","LU0683600562.USD","LU2462157665.USD","SGXZ99366536.SGD","LU0106261372.USD","LU0210536198.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU2746668461.USD","SGXZ81514606.USD","LU2168564222.USD","LU2756315318.SGD","LU0466842654.USD","IE0004445239.USD","LU2089284900.SGD","LU0354030511.USD","LLII","LU0640476718.USD","LU2168564495.EUR","LU2087625088.SGD","LU2237443895.HKD","LLYZ","SG9999014914.USD","BK4581","LU1280957306.USD","LU0471298694.HKD","IE00BK4W5M84.HKD","LU0323591593.USD","LU1061106388.HKD","LU2750360997.AUD","LU0417517546.SGD","LU1064131342.USD","LU2750360641.GBP","BK4588","LU2237443622.USD","LU2237443465.HKD","LU0889565916.HKD","ELIL","NVOH","SG9999015978.USD","SG9999018857.SGD","LU2456880835.USD","LU2213496289.HKD","LU2265009873.SGD","LU2023250330.USD","IE00BKPKM429.USD","LU0114720955.EUR","LU2491050071.SGD","LU1093756325.SGD","LU1868837136.USD","LU0320765059.SGD","LU0820562030.AUD","BK4007","LU0097036916.USD","LU2089283258.USD","LU2491050154.USD","LU0471298777.SGD","LU1023059063.AUD","IE00BKDWB100.SGD","LU1868836591.USD","LU2237438978.USD","LU1623119135.USD","IE00BKVL7J92.USD","LU0354030438.USD","SGXZ57979304.SGD","LU1629891620.HKD","LU1814569148.SGD","LU2168564065.EUR","LU2468319806.SGD","BK4534","LU0320765992.SGD","IE0002141913.USD","LU2552382132.HKD","IE00BFSS7M15.SGD","LU0238689110.USD","SG9999014906.USD","LU0820561818.USD","LU1974910355.USD","IE00BK4W5L77.USD","BK4533","IE00B7KXQ091.USD","LU1035775433.USD","LU2471134523.USD","LU2108987350.USD","LU0787776722.HKD","IE00BJJMRY28.SGD","LU2360106947.USD","SG9999017495.SGD","IE00B775H168.HKD","GPCR","LU0266013472.USD","LU0820561909.HKD","LU2106854487.HKD","LU0109394709.USD","SGXZ51526630.SGD","LU2063271972.USD","SG9999014898.SGD","LU0225283273.USD","SG9999013999.USD","LU2361044949.HKD","IE0005OL40V9.USD","LU0823434583.USD","LU2112291526.USD","LU1720051017.SGD","LU0158827781.USD","LU0786609619.USD","LU2271345857.HKD","LU1983299246.USD","LU2746668974.SGD","LU2023251221.USD","LU1057294990.SGD","SG9999001176.SGD","LU2324357040.USD","SGXZ31699556.SGD","LU0353189680.USD","LU0823434740.USD","IE00B4R5TH58.HKD","LU0316494557.USD","IE0004445015.USD","NVOX","LU2552382058.USD","LU0964807845.USD","LU2028103732.USD","SG9999015945.SGD","LU1868836914.USD","LU1720051108.HKD","LU1232071149.USD","LU0203201768.USD","LU2111349929.HKD","LU1145028129.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140362721","title":"Structure Therapeutics股价上涨6% 公布实验性肥胖症药物中期试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1140362721","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140362721?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 21:32","pubTimestamp":1773667958,"startTime":"0","endTime":"0","summary":"在披露其实验性口服肥胖症药物的中期临床试验数据后，Structure Therapeutics Inc.（股票代码：GPCR）股价今日上涨6%。\n该公司公布的第二阶段研究结果显示，其口服GLP-1受体激动剂GSBR-1292在12周治疗期内展现出显著的减重效果。接受治疗的患者平均体重下降幅度达统计学意义，且药物耐受性良好，未出现严重不良反应。\n这一积极数据令投资者对该公司挑战诺和诺德、礼来等制药巨头的口服减肥药市场前景感到乐观。分析师指出，若后续临床试验继续验证其疗效与安全性，该药物有望成为肥胖症治疗领域的重要竞争者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134097930","title":"Structure Therapeutics股价逆转走势 披露中期试验结果后盘前大涨13.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134097930","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134097930?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 19:24","pubTimestamp":1773660253,"startTime":"0","endTime":"0","summary":"在公布其实验性肥胖症药物的中期临床试验结果后，Structure Therapeutics的股价出现显著逆转。该股在盘前交易中一度飙升13.5%，扭转了此前的下跌趋势。\n此次披露的积极数据主要涉及公司研发的口服肥胖症疗法，该疗法在中期试验中达到了主要终点和关键次要终点，显示出显著的减重效果和良好的安全性特征。这一利好消息提振了投资者信心，推动股价强势反弹。\n市场分析师认为，这一进展不仅验证了该药物的潜力，也为Structure Therapeutics在竞争激烈的减肥药市场中赢得了重要地位。随着肥胖症治疗需求的持续增长，该公司的未来发展前景备受关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160730772","title":"Structure Therapeutics盘前跌1.6% 披露实验性减肥药中期试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1160730772","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160730772?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 19:11","pubTimestamp":1773659469,"startTime":"0","endTime":"0","summary":"在公布其实验性口服减肥药物的中期临床试验数据后，生物制药公司Structure Therapeutics的股价在盘前交易时段下跌1.6%。此次下跌反映了市场对该阶段性成果的初步反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4007","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619452444","title":"研究显示，结构公司的肥胖药片最多可减轻 16.3% 的体重","url":"https://stock-news.laohu8.com/highlight/detail?id=2619452444","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619452444?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 19:04","pubTimestamp":1773659060,"startTime":"0","endTime":"0","summary":"研究显示，结构公司的肥胖药片最多可减轻 16.3% 的体重路透3月16日 - Structure Therapeutics GPCR.O称，在一项中期研究中，其口服肥胖症药物aleniglipron与安慰剂相比，经过44周的治疗后，体重减轻达16.3%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL4S4040WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175317698","title":"Structure Therapeutics公司：FDA二期结束会议定于2026年第二季度；三期试验启动计划于2026年下半年推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1175317698","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175317698?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 19:04","pubTimestamp":1773659040,"startTime":"0","endTime":"0","summary":"Structure Therapeutics公司宣布，其与美国食品药品监督管理局（FDA）的二期临床试验结束会议已正式安排在2026年第二季度举行。此次会议旨在讨论二期试验数据，并为后续的三期临床试验方案提供指导。\n与此同时，公司确认其三期临床试验的启动计划仍按原定时间表推进，预计将在2026年下半年开始。这一进展标志着公司在核心研发项目上迈出了关键一步，为其主要候选药物的未来发展奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144091293","title":"Structure Therapeutics中期数据：2.5毫克起始剂量组不良事件相关停药率为2.0%-3.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144091293","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144091293?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 19:03","pubTimestamp":1773659032,"startTime":"0","endTime":"0","summary":"STRUCTURE THERAPEUTICS INC最新公布的中期临床试验数据显示，采用2.5毫克起始剂量的治疗组中，因不良事件导致停药的发生率介于2.0%至3.4%之间。这一关键指标为评估该药物安全性提供了重要参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120934691","title":"Structure Therapeutics公布每日一次口服小分子GLP-1受体激动剂Aleniglipron二期临床试验积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1120934691","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120934691?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 19:01","pubTimestamp":1773658905,"startTime":"0","endTime":"0","summary":"STRUCTURE THERAPEUTICS INC（股票代码：GPCR）近日宣布，其研发的每日一次口服小分子GLP-1受体激动剂Aleniglipron，在二期ACCESS II临床试验中取得了积极的顶线数据。这一突破性进展标志着公司在代谢性疾病治疗领域迈出了重要一步。\n临床试验结果显示，Aleniglipron在有效性和安全性方面均表现出色，为后续研发奠定了坚实基础。该药物若成功上市，有望为全球数百万糖尿病患者提供更便捷的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173154837","title":"Structure Therapeutics公司ACCESS OLE研究显示：120毫克剂量在56周内实现持续减重，最高达16.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173154837","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173154837?lang=zh_cn&edition=fundamental","pubTime":"2026-03-16 19:01","pubTimestamp":1773658874,"startTime":"0","endTime":"0","summary":"Structure Therapeutics公司最新公布的ACCESS OLE研究数据揭示，其研发的120毫克剂量药物在56周的治疗周期内展现出显著的持续减重效果，患者体重减轻幅度最高可达16.2%。这一结果进一步验证了该药物在体重管理领域的潜在疗效。\n研究数据显示，随着治疗时间的延长，药物的减重效果呈现持续改善的趋势。至56周时，接受120毫克剂量治疗的患者群体实现了平均体重的大幅下降，凸显了该疗法在长期体重控制中的积极作用。\n此次公布的OLE研究结果为公司后续的临床开发及商业化策略提供了重要的数据支持，也为肥胖症患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617650913","title":"用于成人体重管理的新药获批，研究称患者治疗期内体重持续下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2617650913","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617650913?lang=zh_cn&edition=fundamental","pubTime":"2026-03-07 20:17","pubTimestamp":1772885879,"startTime":"0","endTime":"0","summary":"3月6日，辉瑞中国宣布，国家药监局已批准其新一代cAMP偏向型GLP-1受体激动剂埃诺格鲁肽注射液（商品名为先维盈），用于在控制饮食和增加体力活动基础上对成人超重/肥胖患者的长期体重管理。该药也是目前唯一获批、完全由天然氨基酸组成的长效GLP-1药物，研究显示，患者在整个48周治疗期间体重持续下降，未出现平台期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603073665182710.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603073665182710.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148781980","title":"Structure Therapeutics公布2025年末现金及等价物达14亿美元 预计资金可支撑运营至2028年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1148781980","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148781980?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 05:30","pubTimestamp":1772141412,"startTime":"0","endTime":"0","summary":"生物制药企业Structure Therapeutics近日披露，截至2025年12月31日，公司持有的现金及现金等价物规模达14亿美元。这一资金储备预计将为公司现有研发及运营计划提供充足支持，现金流可延续至2028年末。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611698391","title":"硕迪生物盘中异动 大幅下挫5.12%报72.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611698391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611698391?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 04:59","pubTimestamp":1770929957,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日04时59分，硕迪生物股票出现异动，股价急速跳水5.12%。截至发稿，该股报72.09美元/股，成交量42.8565万股，换手率0.61%，振幅6.59%。机构评级方面，在所有16家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213045917a6f4a6c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213045917a6f4a6c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605450753","title":"美国研究综述-Cencora、Crocs、Teledyne Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605450753","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605450753?lang=zh_cn&edition=fundamental","pubTime":"2026-01-22 15:18","pubTimestamp":1769066301,"startTime":"0","endTime":"0","summary":"美国研究综述-Cencora、Crocs、Teledyne Technologies路透1月22日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Cencora、Crocs 和 Teledyne Technologies。* HCA Healthcare Inc HCA.N：杰富瑞将目标价从525美元上调至535美元* Teledyne Technologies Inc TDY.N：Needham将目标价从615美元上调至700美元以下是路透周四报道的美国公司研究报告摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL4S3YN0FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KTOS","CNC","CTSH","SCHW","MKSI","BTSG","LU2413666004.HKD","GOLF","HCA","LU1032955483.USD","BKU","OPCH","TDY","EGBN","IE00B19Z4B17.USD","JNJ","DCOM","GPCR","SSNC","REAL","ACHC","FOLD","BXP","GDRX","KMI","CVLT","LU1066053197.SGD","LU0345770993.USD","COR","NIC","OZK","CFG","CAH","MCB","MOH","RAPT","GLDD","UAL","EOLS","KRMN","ORN","HAL","WTFC","CHE","CROX","WY","LEGN","MRK"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2603679993","title":"硕迪生物(GPCR.US)CEO忧心减肥药仿制冲击：即便药物尚未上市，挑战已在眼前","url":"https://stock-news.laohu8.com/highlight/detail?id=2603679993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603679993?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 14:51","pubTimestamp":1768459909,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，硕迪生物首席执行官Raymond Stevens周三在旧金山举行的摩根大通医疗保健大会上接受采访时表示，硕迪生物的实验性减肥药尚未获得批准，但已开始担心其试验性减肥药的仿制版本大量涌入市场。在礼来和诺和诺德推出减肥针剂后的几年里，由于供应短缺，患者转而使用仿制或配制的减肥药。9月份，该机构在一份声明中表示，为了阻止进口可能存在危险的活性成分仿制品，它将公布一份符合该机构标准的海外供应商名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159085975","title":"Structure Therapeutics首席执行官强调：药品商业化战略伙伴需与基层医疗医生建立稳固关系","url":"https://stock-news.laohu8.com/highlight/detail?id=1159085975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159085975?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 04:05","pubTimestamp":1768421109,"startTime":"0","endTime":"0","summary":"Structure Therapeutics公司首席执行官近日指出，其药物商业化进程中的战略合作伙伴必须具备与初级保健医生群体的深厚联系。这一表态凸显了在医药产品推广阶段，直接触及一线处方决策者的关键性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603764194","title":"Structure 预计到 2030 年，药片将占据 25% 至 50% 的 GLP-1 肥胖症市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2603764194","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603764194?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 03:58","pubTimestamp":1768420720,"startTime":"0","endTime":"0","summary":"Structure 预计到 2030 年，药片将占据 25% 至 50% 的 GLP-1 肥胖症市场份额路透1月14日 - Structure Therapeutics GPCR.O公司周三表示，预计到2030年，口服减肥药将占据GLP-1市场25%至50%的份额。公司首席执行官称，这一乐观估计部分是受患者和医生对口服药物的积压需求所推动。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL4T3YF1TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603378936","title":"未来一天的看点--1 月 14 日星期三","url":"https://stock-news.laohu8.com/highlight/detail?id=2603378936","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603378936?lang=zh_cn&edition=fundamental","pubTime":"2026-01-14 03:33","pubTimestamp":1768332791,"startTime":"0","endTime":"0","summary":"未来一天的看点--1 月 14 日星期三The Day Ahead 是一份电子邮件和 PDF 格式的出版物，内容包括当天的主要新闻和事件、分析和其他专题。从全年来看，生产者价格指数可能上涨 2.7%，与此前涨幅相近。除食品和能源外，11 月份PPI环比增长 0.2%，同比增长 2.7%。另外，美国商务部人口普查局将公布 11 月份零售销售报告，预计将增长 0.4%，10 月份为持平。全美房地产经纪人协会预计 12 月份成屋销售量为 421 万套，高于 11 月份的 413 万套。美联储将在当日安排一系列发言人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4T3YE1WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","LU0820561818.USD","LU2237443382.USD","LU2125154778.USD","IE00BN8TJ469.HKD","LU0496365809.HKD","LU1323610961.USD","LU0868494617.USD","IE00B19Z3581.USD","LU1880398554.USD","IE00BFXG1179.USD","LU0225771236.USD","LU1989771016.USD","GPCR","LU0251131958.USD","BAC","LU2237443622.USD","LU0098860793.USD","LU2264538146.SGD","LU1496350502.SGD","LU1974910355.USD","LU0265550946.USD","LU0310800965.SGD","BK4532","LU2213496289.HKD","LU1116320737.USD","IE00B1XK9C88.USD","LU1670710588.SGD","LU1571399168.USD","LU0323591593.USD","LU0128525689.USD","LU1032466523.USD","IE00BSNM7G36.USD","LU2237443978.SGD","LU1670628061.USD","LU2023250330.USD","LU1585245621.USD","LU1244550494.USD","BK4007","LU1267930490.SGD","LU1244550577.SGD","LU2357305700.SGD","LU0251132253.USD","LU0211327993.USD","LU2381873111.SGD","LU2265009873.SGD","LU1162221912.USD","LU2361045086.USD","LU0314106906.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}